- Ring The Bell
- Posts
- Revolutionizing Diabetes Care: Discover the Future of Continuous Glucose Monitoring
Revolutionizing Diabetes Care: Discover the Future of Continuous Glucose Monitoring

This message is from a valued third-party sponsor. It should not be considered a recommendation or endorsement by Benzinga.
Don’t miss this exclusive opportunity to explore a groundbreaking innovation that could reshape how diabetes is managed. Join us for an inside look at Glucotrack, a cutting-edge medical technology company pushing the boundaries of continuous glucose monitoring (CGM).
Glucotrack is developing a fully implantable, investigational Continuous Blood Glucose Monitor (CBGM)—a next-generation system designed to measure glucose directly from the blood, without any on-body components, and with the potential to last up to three years.
Fresh off successful first-in-human trials, this webinar will dive into the science, the breakthrough results, and what lies ahead for this novel approach to glucose monitoring.
🔍 What You’ll Learn:
How CBGM technology works—and how it could transform life for people with diabetes
The critical role of real-time, continuous blood glucose tracking
Why the current CGM landscape needs a bold new solution
Highlights from Glucotrack’s first-in-human clinical trial
What’s next: details on the newly announced long-term clinical study
When: Thursday, 5/29 at 11:00am EST
Join leading experts and company insiders to get a first-hand look at a technology that could change the game for millions living with diabetes. Register now!
This is a paid ad. Please see 17b disclosure here for more information.